Roger S. McIntyre, MD, FRCPC

Department of Psychiatry, University of Toronto, Toronto, Canada; Department of Pharmacology, University of Toronto, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada.; Corresponding Author: Roger S. McIntyre, MD, FRCPC, Brain and Cognition Discovery Foundation, 77 Bloor St W, Ste 617, Toronto, ON M5S 1M2, Canada ([email protected]).

JCP
Co-occurrence of Depression and Obesity: Implications for Practice and the Discovery of Targeted and Mechanistically Informed Therapeutics
JCP
Risk-Sensitive Decision-Making and Self-Harm
JCP
Vortioxetine vs Desvenlafaxine in Patients With MDD
PCC
Screening for Bipolar Disorder and Evaluating the RMS
JCP
Efficacy of Lumateperone in Bipolar Depression With Mixed Features
JCP
Patient Functioning and Life Engagement: Treatment Goals in MDD
JCP
Patient Functioning, Life Engagement, and Treatment Goals in Major Depressive Disorder
JCP
Patient Functioning and Life Engagement: Treatment Goals in Schizophrenia
JCP
Patient Functioning, Life Engagement, and Treatment Goals in Schizophrenia
JCP
Patient Functioning and Life Engagement: Unmet Needs in MDD and Schizophrenia
JCP
Patient Functioning and Life Engagement: Unmet Needs in MDD and Schizophrenia
JCP
Distinguishing Bipolar Disorder From MDD: Points to Remember